X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (17) 17
oncology (14) 14
hematology, oncology and palliative medicine (12) 12
radiology (12) 12
radiology, nuclear medicine & medical imaging (12) 12
radiotherapy (10) 10
male (9) 9
radiation oncology - standards (9) 9
cancer (8) 8
prostate cancer (8) 8
radiology and nuclear medicine (7) 7
biochemistry & molecular biology (6) 6
cell biology (6) 6
neoplasms (6) 6
prostate (6) 6
prostatic neoplasms - radiotherapy (6) 6
radiation (6) 6
care and treatment (5) 5
female (5) 5
middle aged (5) 5
settore med/27 - neurochirurgia (5) 5
societies, medical - standards (5) 5
therapy (5) 5
united states (5) 5
adult (4) 4
aged (4) 4
biochemistry, genetics and molecular biology (4) 4
medicine (4) 4
organs (4) 4
radical prostatectomy (4) 4
radiotherapy dosage (4) 4
radiotherapy, conformal - standards (4) 4
recommendations (4) 4
tcga (4) 4
androgen suppression (3) 3
body (3) 3
brachytherapy (3) 3
brachytherapy - methods (3) 3
databases, genetic (3) 3
deprivation (3) 3
diseases (3) 3
glands (3) 3
health aspects (3) 3
medical colleges (3) 3
medical personnel (3) 3
neoplasms - genetics (3) 3
neoplasms - pathology (3) 3
nuclear medicine (3) 3
patient selection (3) 3
pelvis (3) 3
prostate-cancer (3) 3
prostatic neoplasms - pathology (3) 3
quality control (3) 3
radiotherapy planning, computer-assisted - standards (3) 3
research (3) 3
technology, radiologic - standards (3) 3
urinary bladder - diagnostic imaging (3) 3
aged, 80 and over (2) 2
analysis (2) 2
androgen antagonists - therapeutic use (2) 2
aneuploidy (2) 2
appropriateness criteria (2) 2
breast (2) 2
cancer genomics (2) 2
carcinoma (2) 2
cat scanning (2) 2
chemotherapy (2) 2
chemotherapy, adjuvant - adverse effects (2) 2
classification (2) 2
clinical trials (2) 2
conformal radiotherapy (2) 2
copy-number alteration (2) 2
discovery (2) 2
dosimetry (2) 2
drug administration schedule (2) 2
external-beam radiation (2) 2
external-beam radiotherapy (2) 2
genomics (2) 2
health physics - standards (2) 2
inhibition (2) 2
interstitial brachytherapy (2) 2
irradiation (2) 2
kinase (2) 2
landscape (2) 2
lymph nodes (2) 2
lymph nodes - diagnostic imaging (2) 2
lymphatic irradiation - standards (2) 2
male genitals (2) 2
medical records - standards (2) 2
mutation (2) 2
neoadjuvant (2) 2
patient education as topic - standards (2) 2
patient satisfaction (2) 2
pelvic lymph nodes (2) 2
pelvis - diagnostic imaging (2) 2
personnel (2) 2
phase-iii trial (2) 2
physicists (2) 2
physics - standards (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. e353 - e362
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 2, pp. 361 - 368
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 383 - 387
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 377 - 382
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 2, pp. 335 - 341
Transperineal permanent prostate brachytherapy is a safe and efficacious treatment option for patients with organ-confined prostate cancer. Careful adherence... 
Radiology | Hematology, Oncology and Palliative Medicine | Prostate Cancer | Brachytherapy | Safety | Dosimetry | Quality Assurance | ANDROGEN SUPPRESSION | RANDOMIZED MULTICENTER TRIAL | INTEROBSERVER VARIABILITY | BIOCHEMICAL FAILURE | RADICAL PROSTATECTOMY | INTERSTITIAL BRACHYTHERAPY | PHASE-III TRIAL | SEED IMPLANTATION | ONCOLOGY | EXTERNAL-BEAM RADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SURVIVAL OUTCOMES | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Health Physics - education | United States | Humans | Brachytherapy - methods | Technology, Radiologic - standards | Male | Diagnostic Imaging - standards | Certification | Patient Selection | Guideline Adherence | Radiation Oncology - education | Androgen Antagonists - therapeutic use | Accreditation | Societies, Medical - standards | Health Physics - standards | Technology, Radiologic - education | Quality Control | Radiation Oncology - standards | Physicists | Universities and colleges | Radioisotope brachytherapy | Prostate cancer | PROSTATE | NEOPLASMS | QUALITY ASSURANCE | MALE GENITALS | MEDICAL PERSONNEL | RADIATION PROTECTION | MEDICINE | NUCLEAR MEDICINE | ORGANS | PERSONNEL | DISEASES | THERAPY | GLANDS | RECOMMENDATIONS | RADIOLOGICAL PERSONNEL | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BRACHYTHERAPY | BODY | RADIOLOGY
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 3, pp. 672 - 678
Purpose Long-term androgen suppression plus radiotherapy (AS+RT) is standard treatment of high-risk prostate cancer. A randomized trial, Radiation Therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Chemotherapy | Randomized clinical trials | Toxicity | Prostate cancer | SURVIVAL | ONCOLOGY | DEPRIVATION | EORTC | GROUP PROTOCOL 92-02 | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Thromboembolism - chemically induced | Estramustine - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thromboembolism - prevention & control | Chemotherapy, Adjuvant - adverse effects | Myelodysplastic Syndromes - chemically induced | Aged, 80 and over | Adult | Leukemia, Myeloid, Acute - chemically induced | Paclitaxel - administration & dosage | Prostatic Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Paclitaxel - adverse effects | Etoposide - administration & dosage | Combined Modality Therapy - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Estramustine - adverse effects | Paclitaxel | Radiation | Etoposide | Clinical trials | Product development | Radiotherapy | Cancer | Index Medicus | PROSTATE | PATIENTS | INHIBITION | CLINICAL TRIALS | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | TOXICITY | LEUKEMIA | RADIOTHERAPY | ANDROGENS | CHEMOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 3, pp. 641 - 649
High-Dose-Rate (HDR) brachytherapy is a safe and efficacious treatment option for patients with a variety of different malignancies. Careful adherence to... 
Radiology | Hematology, Oncology and Palliative Medicine | Dosimetry | Safety | Quality Assurance | High-Dose-Rate (HDR) Brachytherapy | ORAL TONGUE CANCER | LOCALIZED PROSTATE-CANCER | AFTERLOADING INTRALUMINAL BRACHYTHERAPY | T2 EPIDERMOID CARCINOMAS | RATE HDR BRACHYTHERAPY | RATE INTRAOPERATIVE BRACHYTHERAPY | RATE INTRACAVITARY THERAPY | ONCOLOGY | EXTERNAL-BEAM IRRADIATION | SQUAMOUS-CELL CARCINOMA | RECURRENT RECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Brachytherapy - instrumentation | United States | Humans | Brachytherapy - methods | Male | Urologic Neoplasms - radiotherapy | Genital Neoplasms, Female - radiotherapy | Patient Selection | Head and Neck Neoplasms - radiotherapy | Thoracic Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Soft Tissue Neoplasms - radiotherapy | Gastrointestinal Neoplasms - radiotherapy | Brachytherapy - standards | Female | Societies, Medical - standards | Quality Assurance, Health Care - standards | Health Physics - standards | Radiation Oncology - standards | DOCUMENTATION | HEAD | MAMMARY GLANDS | NEOPLASMS | QUALITY ASSURANCE | MEDICAL PERSONNEL | RADIATION PROTECTION | MEDICINE | NUCLEAR MEDICINE | ORGANS | PERSONNEL | DISEASES | THERAPY | GLANDS | RECOMMENDATIONS | RADIOLOGICAL PERSONNEL | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | BRACHYTHERAPY | BODY | RADIOLOGY
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 12/2018, Volume 129, Issue 3, pp. 421 - 426
Artificial intelligence (AI) is emerging as a technology with the power to transform established industries, and with applications from automated manufacturing... 
Deep learning | Artificial intelligence | Machine learning | UNITED-STATES | LUNG-CANCER PATIENTS | AT-RISK | LEARNING HEALTH-CARE | DOSE-VOLUME | NECK-CANCER | DECISION-SUPPORT | ONCOLOGY | CLINICAL-DATA | BIG DATA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIOTHERAPY RESEARCH | Radiation | Medical imaging equipment
Journal Article
by Ding, Li and Bailey, Matthew H and Thorsson, Vesteinn and Colaprico, Antonio and Bertrand, Denis and Gibbs, David L and Weerasinghe, Amila and Cortés-Ciriano, Isidro and Chen, Feng and Yu, Lihua and Olsen, Catharina and Cherniack, Andrew D and Akbani, Rehan and Suphavilai, Chayaporn and Mills, Gordon B and Wyczalkowski, Matthew A and Vincent, Benjamin G and Hutter, Carolyn M and Hoadley, Katherine A and Shmulevich, llya and Lazar, Alexander J and Wheeler, David A and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Sofia, Heidi J and Yang, Liming and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Chudamani, Sudha and Naresh, Rashi and Sun, Qiang and Wan, Yunhu and Wu, Ye and DeFreitas, Timothy and Frazer, Scott and Heiman, David I and Lin, Pei and Meier, Sam and Saksena, Gordon and Zhang, Hailei and Bernard, Brady and Chambwe, Nyasha and Leinonen, Kalle and Liu, Yuexin and Miller, Michael and Shmulevich, Ilya and Zhang, Wei and Broom, Bradley M and Hegde, Apurva M and Ju, Zhenlin and Kanchi, Rupa S and Korkut, Anil and Li, Jun and Liang, Han and Liu, Wenbin and Lu, Yiling and Ng, Kwok-Shing and Rao, Arvind and Ryan, Michael and Wang, Jing and Weinstein, John N and Zhang, Jiexin and Abeshouse, Adam and Armenia, Joshua and Chakravarty, Debyani and Gao, Jianjiong and Gross, Benjamin E and Kundra, Ritika and La, Konnor and Ladanyi, Marc and Luna, Augustin and Ochoa, Angelica and Phillips, Sarah M and Reznik, Ed and Schultz, Nikolaus and Sheridan, Robert and Sumer, S. Onur and Taylor, Barry S and Wang, Jioajiao and Zhang, Hongxin and Anur, Pavana and Wong, Christopher K and Hayes, D. Neil and Parker, Joel S and Wilkerson, Matthew D and Ally, Adrian and Balasundaram, Miruna and Bowlby, Reanne and Carlsen, Rebecca and Chuah, Eric and Lee, Darlene and Marra, Marco A and Moore, Richard A and Mungall, Karen and Sadeghi, Sara and Tam, Angela and Thiessen, Nina and Tse, Kane and Wong, Tina and ... and The Cancer Genome Atlas Research Network and Cancer Genome Atlas Res Network and Cancer Genome Atlas Research Network and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Cell (Cambridge), ISSN 0092-8674, 04/2018, Volume 173, Issue 2, pp. 305 - 320.e10
Journal Article